
Specializing in Treatment of Advanced Depression with TMS
- Have you tried more than one antidepressant medication?
- Have medications failed to provide sufficient relief from your depression?
- Do the side effects of medication outweigh their benefits?
- Has depression led to increased visits to your doctor for other health concerns?
- Is depression interfering with your ability to work or earn a living?
- Does depression still feel like it has too much control over your life?
- History of seizures or recent brain injury
- Presence of metal/magnetic implants near the brain (excluding dental fillings)
- Active psychosis or suicidal behavior
- Substance abuse or withdrawal
- Pregnancy (currently under research for safety and efficacy)
- Non-Invasive, Non-Systemic, Non-Pharmacological, and Non-Sedating
- Does not cause cognitive side effects
- Targeted and Highly Effective
- Covered by Insurance
- Proven Efficacy Since FDA Approval
- High Response and Remission Rates
- Cost-Effective Long Term
- Targeted, Non-Systemic Treatment
- No Major or Prolonged Side Effects
- FDA Approved
- Covered by Insurance Plans
- Time Commitment
- Temporary Mild Side Effects
- Low Seizure Risk
- Insurance Coverage Limitations
- Accessibility Challenges
- Lack of Public Awareness
1. High Success Rate
TMS therapy has shown consistently high success rates, particularly for Treatment-Resistant Depression (TRD). Research and real-world data indicate:
- Response Rate (significant symptom improvement): 60-70%
- Remission Rate (full symptom resolution): 40-50%
These outcomes are particularly impressive given that most TMS patients have failed at least two antidepressant trials. By comparison, the likelihood of success with a third medication is only 15-20%, dropping even further with additional trials.
2. Prolonged Response
TMS offers not only immediate benefits but also sustained improvements:
- Approximately two-thirds of patients maintain their response a year after treatment.
- For those who relapse, repeat TMS therapy is highly effective, with more than 75% achieving a positive response.
This contrasts sharply with antidepressant therapies, where only one-third of patients on a third medication remain depression-free after one year, and the likelihood of success drops to 10% or less upon medication reintroduction.
3. Non-Invasive and does not require anesthesia
TMS uses magnetic fields to stimulate brain activity without inducing seizures or requiring anesthesia, unlike Electroconvulsive Therapy (ECT). Key safety features include:
- Does not affect cognitive function.
- Targeted Stimulation: Focuses on specific brain circuits linked to depression and anxiety.
- Minimal Risk of Seizures: Less than 1 in 30,000 treatments.
- No Recovery Time: Patients remain awake, alert, and can resume daily activities immediately after treatment.
